2 Information about ustekinumab
2.3 The list price of ustekinumab is £2,147 per 130‑mg vial of concentrate for solution for infusion, and £2,147 per 90‑mg solution for injection in a pre-filled syringe (excluding VAT; BNF online accessed February 2020).
2.4 The annual treatment costs are £14,482 in the induction year, and £9,304 per year for maintenance treatment (year 2 onwards).
2.5 The company has agreed a nationally available price reduction for ustekinumab with the Commercial Medicines Unit. The prices agreed through the framework are commercial in confidence.